About Girindus
Our Story, Mission, and Commitment to Excellence
Our Story
Founded in 1998, Girindus emerged from a vision to revolutionize the field of oligonucleotide production. What began as a small research-focused operation has grown into a leading provider of chemical manufacturing and consultancy services in the oligonucleotides industry.
Over the past two decades, we have continuously evolved our methodologies, expanded our capabilities, and built a team of world-class experts dedicated to advancing the science of oligonucleotide synthesis and production.
Today, Girindus stands at the forefront of the industry, known for our commitment to quality, innovation, and customer satisfaction. Our state-of-the-art facilities and proprietary processes enable us to deliver exceptional products and services to clients worldwide.
Our Mission
At Girindus, our mission is to accelerate scientific progress and improve global health outcomes by providing the highest quality oligonucleotides and chemical manufacturing services to researchers, pharmaceutical companies, and biotechnology firms.
We are committed to:
- Maintaining the highest standards of quality and purity in all our products
- Continuously innovating to improve efficiency and reduce costs
- Providing expert consultancy to help clients optimize their processes
- Supporting the development of novel therapeutics and diagnostic tools
- Operating with integrity, transparency, and environmental responsibility
Our Vision
We envision a future where advanced oligonucleotide technologies are accessible to all researchers and healthcare providers, enabling breakthroughs in personalized medicine, genetic therapies, and diagnostic technologies.
Girindus aims to be the catalyst for this transformation by providing the expertise, products, and services needed to bridge the gap between scientific discovery and practical application.
Why Chemical Manufacturing and Consultancy in Oligonucleotides Production Matters
Advancing Medical Research
Oligonucleotides are essential components in the development of novel therapeutics, including antisense therapies, siRNA, and CRISPR-based gene editing. High-quality production is critical for research success and patient safety.
Enabling Precision Medicine
As medicine moves toward personalized approaches, oligonucleotides play a crucial role in diagnostics, targeted therapies, and genetic testing. Reliable manufacturing ensures accurate results and effective treatments.
Accelerating Drug Development
Efficient, high-quality oligonucleotide production accelerates the pace of drug discovery and development, bringing life-saving treatments to patients faster and at lower costs.
Supporting Sustainability
Modern oligonucleotide production methods can be optimized for efficiency and environmental sustainability, reducing waste and resource consumption in pharmaceutical manufacturing.
Meet Our Founder
Dr. Elizabeth Chen
Founder & Chief Scientific Officer
Dr. Elizabeth Chen founded Girindus in 1998 with a vision to transform oligonucleotide production. With a Ph.D. in Biochemistry from MIT and over 15 years of experience in pharmaceutical research, Dr. Chen identified critical gaps in the quality and accessibility of custom oligonucleotide synthesis services.
Her passion for advancing genetic medicine stems from personal experience—her sister's battle with a rare genetic disorder inspired her to pursue a career in nucleic acid therapeutics. Dr. Chen's groundbreaking work in improving the efficiency and scale of oligonucleotide synthesis has earned her multiple industry awards and patents.
"I founded Girindus because I believe that high-quality oligonucleotides should be accessible to every researcher working to solve our most pressing health challenges. Our work is about more than chemistry—it's about enabling the next generation of life-saving treatments."
Our Leadership Team
Dr. Michael Lin
Chief Technology Officer
20+ years of experience in oligonucleotide synthesis and automation
Dr. Sarah Johnson
Director of Quality Assurance
Expert in GMP compliance and quality control methodologies
Robert Garcia
Chief Operations Officer
Specializes in scaling production and operational excellence
Dr. Julia Park
Head of Research & Development
Leading innovations in nucleic acid chemistry and synthesis methods
Partner with Girindus for Your Oligonucleotide Needs
Discover how our expertise can support your research, development, and production goals.
Contact Us Today